Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeina A Kanafani

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Expert Review of Anti-Infective Therapy|December 5, 2006
Telavancin: a new lipoglycopeptide with multiple mechanisms of actionZeina A Kanafani
Future Microbiology|December 18, 2010
Ceftaroline fosamil: drug profile and clinical dataZeina A Kanafani
Expert Review of Anti-Infective Therapy|June 11, 2015
Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infectionsTamara Nawar, Zeina A Kanafani
Core Evidence|February 25, 2015
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based reviewJoumana Kmeid, Zeina A Kanafani
Infectious Disease Clinics of North America|September 23, 2018
Vascular Graft Infections: An updateAmal Gharamti, Zeina A Kanafani
Enfermedades Infecciosas Y Microbiologia Clinica|April 12, 2006
[Staphylococcus aureus infections: new challenges from an old pathogen]Zeina A Kanafani, Vance G Fowler
Future Microbiology|February 12, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activityZeina A Kanafani, G Ralph Corey
Expert Opinion on Investigational Drugs|February 14, 2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potencyZeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impactZeina A Kanafani, John R Perfect
Expert Review of Anti-Infective Therapy|April 4, 2007
Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infectionsZeina A Kanafani, G Ralph Corey
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Expert Review of Anti-Infective Therapy|December 5, 2006
Telavancin: a new lipoglycopeptide with multiple mechanisms of actionZeina A Kanafani
Future Microbiology|December 18, 2010
Ceftaroline fosamil: drug profile and clinical dataZeina A Kanafani
Expert Review of Anti-Infective Therapy|June 11, 2015
Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infectionsTamara Nawar, Zeina A Kanafani
Core Evidence|February 25, 2015
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based reviewJoumana Kmeid, Zeina A Kanafani
Infectious Disease Clinics of North America|September 23, 2018
Vascular Graft Infections: An updateAmal Gharamti, Zeina A Kanafani
Enfermedades Infecciosas Y Microbiologia Clinica|April 12, 2006
[Staphylococcus aureus infections: new challenges from an old pathogen]Zeina A Kanafani, Vance G Fowler
Future Microbiology|February 12, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activityZeina A Kanafani, G Ralph Corey
Expert Opinion on Investigational Drugs|February 14, 2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potencyZeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impactZeina A Kanafani, John R Perfect
Expert Review of Anti-Infective Therapy|April 4, 2007
Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infectionsZeina A Kanafani, G Ralph Corey
Pageof 9